Literature DB >> 21414357

Clinical manifestations and socio-economic impact of influenza among healthy children in the community.

Susanna Esposito1, Luigi Cantarutti, Claudio Giuseppe Molteni, Cristina Daleno, Alessia Scala, Claudia Tagliabue, Claudio Pelucchi, Carlo Giaquinto, Nicola Principi.   

Abstract

OBJECTIVES: To evaluate the total burden of influenza among healthy children in the community in order to analyse the cost of influenza in paediatric age.
METHODS: This prospective study involved a total community population of 21,986 children, 6988 of whom experienced an influenza-like illness (ILI) between 1 November 2008 and 30 April 2009. An electronic chart was completed, a nasopharyngeal swab was obtained, and information was recorded concerning the clinical outcomes and household impact of the ILI episodes. Influenza A and B viruses were detected in all the swabs by means of polymerase chain reaction, and costs of the disease were calculated.
RESULTS: Influenza viruses were detected in 2143 cases (30.7%), an incidence of 96.4 per 1000 children. Influenza A and B viruses were found in respectively 1751 (81.7%) and 392 cases (18.3%). The mean cost of influenza was no less than €130, 32% higher than the cost of influenza-negative ILIs (p < 0.001). The influenza A cases were significantly more expensive than the influenza B cases (p < 0.001), and influenza in children aged <2 and 2-5 years was significantly more expensive than in children aged >5 years (p < 0.05). The differences were mainly related to the indirect costs of the parents' lost working days.
CONCLUSIONS: The findings of this study confirm that influenza among healthy children is important because of its frequency and its indirect consequences on the households of infected children, and support the use of influenza vaccination in healthy children aged between 6 months and 5 years.
Copyright © 2011 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21414357     DOI: 10.1016/j.jinf.2011.02.015

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  38 in total

1.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

2.  Influenza vaccine effectiveness estimates against influenza A(H3N2) and A(H1N1) pdm09 among children during school-based outbreaks in the 2016-2017 season in Beijing, China.

Authors:  Li Zhang; Wim van der Hoek; Thomas Krafft; Eva Pilot; Liselotte van Asten; Ge Lin; Shuangsheng Wu; Wei Duan; Peng Yang; Quanyi Wang
Journal:  Hum Vaccin Immunother       Date:  2019-11-01       Impact factor: 3.452

3.  [Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra®].

Authors:  Sara Boccalini; Elena Pariani; Giovanna Elisa Calabrò; Chiara DE Waure; Donatella Panatto; Daniela Amicizia; Piero Luigi Lai; Caterina Rizzo; Emanuele Amodio; Francesco Vitale; Alessandra Casuccio; Maria Luisa DI Pietro; Cristina Galli; Laura Bubba; Laura Pellegrinelli; Leonardo Villani; Floriana D'Ambrosio; Marta Caminiti; Elisa Lorenzini; Paola Fioretti; Rosanna Tindara Micale; Davide Frumento; Elisa Cantova; Flavio Parente; Giacomo Trento; Sara Sottile; Andrea Pugliese; Massimiliano Alberto Biamonte; Duccio Giorgetti; Marco Menicacci; Antonio D'Anna; Claudia Ammoscato; Emanuele LA Gatta; Angela Bechini; Paolo Bonanni
Journal:  J Prev Med Hyg       Date:  2021-09-10

4.  The coming era of quadrivalent human influenza vaccines: who will benefit?

Authors:  Ian G Barr; Lauren L Jelley
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

5.  Economic burden of influenza illness among children under 5 years in Suzhou, China: Report from the cost surveys during 2011/12 to 2016/17 influenza seasons.

Authors:  Yin Wang; Liling Chen; Fangfang Cheng; Matthew Biggerstaff; Sujian Situ; Suizan Zhou; Junmei Gao; Changpeng Liu; Jun Zhang; Alexander J Millman; Tao Zhang; Jianmei Tian; Genming Zhao
Journal:  Vaccine       Date:  2021-01-23       Impact factor: 3.641

Review 6.  Burden of paediatric influenza in Western Europe: a systematic review.

Authors:  Evgeniya N Antonova; Catherine E Rycroft; Christopher S Ambrose; Terho Heikkinen; Nicola Principi
Journal:  BMC Public Health       Date:  2012-11-12       Impact factor: 3.295

7.  Viral shedding in children infected by pandemic A/H1N1/2009 influenza virus.

Authors:  Susanna Esposito; Cristina Daleno; Fausto Baldanti; Alessia Scala; Giulia Campanini; Francesca Taroni; Emilio Fossali; Claudio Pelucchi; Nicola Principi
Journal:  Virol J       Date:  2011-07-13       Impact factor: 4.099

8.  Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study.

Authors:  Mariana Galante; Olatz Garin; Elisa Sicuri; Francesc Cots; Anna García-Altés; Montserrat Ferrer; Àngela Dominguez; Jordi Alonso
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

9.  Seasonal influenza immunization in early infancy?

Authors:  Maurizio Bonati; Antonio Clavenna
Journal:  BMC Public Health       Date:  2012-10-15       Impact factor: 3.295

10.  A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years.

Authors:  Joseph B Domachowske; Heidemarie Pankow-Culot; Milagros Bautista; Yang Feng; Carine Claeys; Mathieu Peeters; Bruce L Innis; Varsha Jain
Journal:  J Infect Dis       Date:  2013-03-07       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.